UK markets closed
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • FTSE 250

    22,336.10
    +266.79 (+1.21%)
     
  • AIM

    1,236.38
    +11.54 (+0.94%)
     
  • GBP/EUR

    1.1612
    -0.0014 (-0.12%)
     
  • GBP/USD

    1.4088
    +0.0037 (+0.26%)
     
  • BTC-GBP

    35,952.65
    +1,588.12 (+4.62%)
     
  • CMC Crypto 200

    1,419.12
    +60.56 (+4.46%)
     
  • S&P 500

    4,172.25
    +59.75 (+1.45%)
     
  • DOW

    34,379.54
    +358.09 (+1.05%)
     
  • CRUDE OIL

    65.23
    +1.41 (+2.21%)
     
  • GOLD FUTURES

    1,838.20
    +14.20 (+0.78%)
     
  • NIKKEI 225

    28,084.47
    +636.46 (+2.32%)
     
  • HANG SENG

    28,027.57
    +308.90 (+1.11%)
     
  • DAX

    15,416.64
    +216.96 (+1.43%)
     
  • CAC 40

    6,385.14
    +96.81 (+1.54%)
     

The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.2 billion in 2020, at a CAGR of 6.3% from 2020 to 2025

ReportLinker
·4-min read

The rising incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the PCR technologies market along with the availability of strong financial support in the form of investments, funds, and grants.

New York, April 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "PCR Technologies Market by Technology, Product, Application, Enduser -Global Forecast to 2025" - https://www.reportlinker.com/p06067221/?utm_source=GNW
These factors are driving the growth of PCR technologies market during the forecast period. However, high instrument costs—especially that of dPCR—and the technical limitations of PCR are expected to limit market growth to a certain extent.

The qPCR segment is expected to account for the largest market share of the global PCR technologies market in 2020.
The qPCR segment is expected to account for the largest share among PCR techniques in 2020. The expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing private-public funding for life sciences research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples) are expected to drive the growth of the qPCR market.

Reagents and consumables segment to show the highest growth in the PCR technologies market during the forecast period.
The reagents and consumables segment will show the highest growth in the PCR technologies market during the forecast period.The growth of this segment can be attributed to factors such as the expanding applications of dPCR, the increasing number of dPCR-based analytical procedures among institutional researchers (such as CROs and pharma-biotech companies), and the rising availability of novel dPCR reagents worldwide.

Additionally, the expansion of the application base of the dPCR technology in genetic/molecular research, clinical diagnosis, and forensics is expected to result in the commercialization of novel dPCR reagents.

North America to account for the largest share of the global market in 2020.
North America accounts for the largest share of the PCR technologies market owing to the high incidence of chronic and genetic diseases, rising geriatric population, growing adoption of PCR techniques in research & academia, and significant public-private funding in the field of genome analysis. Further, the strong presence of major pharmaceutical and biotechnology companies in the US and ongoing initiatives by the Canadian government to support life science, genomic, and clinical research are other few factors influencing the demand for PCR products in this region

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 - 48%, Tier 2: 36%, and Tier 3: 16%
• By Designation: C-level 10%, D-level: 14%, and Others: 76%
• By Region: North America: 40%, Europe: 32%, APAC: 20%, Latin America: 5%, and the Middle East & Africa: 3%

The major players in the market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), Analytik Jena AG (Germany), Becton Dickinson and Company (US), bioMérieux S.A. (France), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Fluidigm Corporation (US), Merck KGaA (Germany), Promega Corporation (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (US).

Research Coverage
This report studies the PCR technologies market based on product and services, application, end user, and region.The report also studies factors such as drivers, restraints, opportunities, and challenges affecting the market growth.

It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and the respective countries in these regions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the market, and high-growth regions, as well as their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Read the full report: https://www.reportlinker.com/p06067221/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001